Theriva Biologics Receives Notice Of Allowance For US Patent Application Titled "Beta-Lactamase Formulations & Uses Thereof" For Treating C. Difficile Disease And Other Antibiotic-Induced GI Tract Adverse Effects
Author: Benzinga Newsdesk | August 28, 2024 03:58pm